Trials / Sponsors / Crossignal Therapeutics, Inc.
Crossignal Therapeutics, Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2024-09-20 |